Evidence map›Paper›PMID 42089370›Full record

ReviewBiochemical Society transactions2026

MGRN1 in development and disease: a unifying view of a versatile membrane-tethered E3 ubiquitin ligase.

Alyssa Riglos, Teresa M Gunn, Jennifer H Kong

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alyssa RiglosDepartment of Biochemistry, School of Medicine, University of Washington, Seattle, Washington, U.S.A.ORCID 0009-0002-8797-0060
Teresa M GunnMcLaughlin Research Institute and Weissman Hood Institute at Touro University, Great Falls, Montana, U.S.A.ORCID 0000-0003-2688-6420
Jennifer H KongDepartment of Biochemistry, School of Medicine, University of Washington, Seattle, Washington, U.S.A.ORCID 0000-0002-4573-3270

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Modulation of Exosome Release for Functional Restoration in Age-related Retinal DisordersP20GM152335 · NIGMS · MC LAUGHLIN RESEARCH INSTITUTE · PI Brenda F Canine · 2024 to 2026
$11.1M
Molecular mechanisms that regulate target cell sensitivity to Hedgehog morphogensR00GM132518 · NIGMS · UNIVERSITY OF WASHINGTON · PI KONG, JENNIFER · 2023 to 2025
$871k
Molecular mechanisms that regulate target cell sensitivity to Hedgehog morphogensK99GM132518 · NIGMS · STANFORD UNIVERSITY · PI KONG, JENNIFER · 2019 to 2021
$281k
HHS | National Institutes of Health (NIH) GM132518HHS | National Institutes of Health (NIH) P20GM152335HHS | National Institutes of Health (NIH) P30CA015704NCI NIH HHS P30 CA015704NIGMS NIH HHS K99 GM132518NIGMS NIH HHS P20 GM152335NIGMS NIH HHS R00 GM132518
6 · The paper itself

Abstract

Mahogunin Ring Finger 1 (MGRN1) is a multifunctional E3 ubiquitin ligase with broad biological significance and belongs to a small group of membrane-tethered E3s capable of regulating signaling receptors at the plasma membrane. Studies in mice first revealed its physiological importance, as loss of Mgrn1 leads to a wide range of phenotypes, including abnormal pigmentation, congenital malformations, and neurodegeneration. Remarkably, MGRN1 localizes to multiple cellular compartments, including the plasma membrane, mitochondria, nucleus, and endo-lysosomal pathway. MGRN1 is also involved in several cellular processes, including receptor regulation, protein homeostasis, and mitochondrial maintenance. While studies have emphasized the importance of MGRN1, it has been difficult to define unifying principles governing its function. In the present review, we summarize and integrate published findings to develop a clearer picture of MGRN1's roles, focusing on phenotypes observed in mouse models and the signaling pathways MGRN1 regulates. We propose shared mechanistic themes that reconcile the functional diversity of this unique E3 ligase, highlight gaps in the current literature, and identify areas for further investigation to better understand MGRN1's role in disease and evaluate its potential relevance for targeted protein degradation strategies.

Indexed as

Cell MembraneUbiquitin-Protein LigasesAnimalsHumansMiceSignal TransductionUbiquitinationMGRN1 protein, humanMgrn1 protein, mouseUbiquitin-Protein LigasesE3 ubiquitin ligaseGPCR traffickingMGRN1receptor regulationsubstrate specificityubiquitination

Identifiers

PMID42089370
PMCPMC13161197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.